Table1_Treatment of refractory immune-mediated necrotizing myopathy with efgartigimod.docx

Table1_Treatment of refractory immune-mediated necrotizing myopathy with efgartigimod.docx

Objective<p>We aimed to explore the efficacy and safety of efgartigimod in patients with refractory immune-mediated necrotizing myopathy (IMNM).</p>Methods<p>This open-label pilot observational study included seven patients with refractory IMNM, all of whom received intravenous efg...

Full description

Saved in:
Bibliographic Details
Main Author: MengTing Yang (19925814) (author)
Other Authors: JingChu Yuan (19925817) (author), YiKang Wang (19925820) (author), HongJun Hao (19925823) (author), Wei Zhang (405) (author), ZhaoXia Wang (19925826) (author), Yun Yuan (748928) (author), YaWen Zhao (19925829) (author)
Published: 2024
Subjects:
Immunology
Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
Autoimmunity
Cellular Immunology
Humoural Immunology and Immunochemistry
Immunogenetics (incl. Genetic Immunology)
Innate Immunity
Transplantation Immunology
Tumour Immunology
Immunology not elsewhere classified
Genetic Immunology
Animal Immunology
Veterinary Immunology
immune-mediated necrotizing myopathy
efgartigimod
refractory
anti-signal recognition particle
anti-3-hydroxy-3-methylglutaryl-CoA reductase
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items